Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results
Data from this real-world cohort of PLHIV who received cabotegravir/rilpivirine LA injections suggest that this regimen is effective and well tolerated. Virological failures were not associated with the acquisition of resistance mutations.
Authors
- Florence Damond
- Valentine Marie Ferré (ORCID: https://orcid.org/0000-0002-2196-6141)
- Jade Ghosn (ORCID: https://orcid.org/0000-0003-2914-959X)
- Quentin Le Hingrat (ORCID: https://orcid.org/0000-0001-9017-4941)
- Alexandra Serris
- Charlotte Charpentier (ORCID: https://orcid.org/0000-0002-6441-7054)
- Gilles Peytavin (ORCID: https://orcid.org/0000-0002-4359-537X)
- Antoine Bachelard (ORCID: https://orcid.org/0000-0002-4682-4916)
- Yazdan Yazdanpanah
- Marina Exarchopoulos
- Roland Landman
- Diane Descamps
- Véronique Joly
- Bao-Chau Phung
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Bichat-Claude-Bernard (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1093/jac/dkae308
- Citations
- 15
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.84